Welcome to Terry Communications

POL Bulletin

Having a lab problem? Dealing with false negatives or false positives? Have a problem with test validation? Contamination issues plaguing your laboratory?
E-mail Ask The Expert.

Welcome

Mark Terry is writer and editor specializing in health care, biotechnology, and clinical laboratory business and medicine. He earned a B.S. in microbiology and public health from Michigan State University and worked in clinical cytogenetics and infectious disease research for 18 years before turning to writing.

In The News

To Download a Free Copy of the August Issue of the POL BULLETIN, Visit the POL BULLETIN Page! The September issue is now available. If interested, e-mail This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Terry Communications, LLC has discontinued publication of POL Bulletin.

September 25, 2009

Axial Biotech Announces Commercial Availability of SCOLISCORE(TM) AIS Prognostic Test

Axial Biotech, Inc., a company personalizing spine care through the development of molecular diagnostics, announced today that its SCOLISCORE(TM) AIS Prognostic Test is now being made available to spine specialists in the United States. SCOLISCORE is a saliva-based genetic test designed to predict the risk of progression of scoliosis, an abnormal lateral curvature of the spine. Spine surgeons from 40 medical centers throughout the U.S. were introduced to the test and have been defining its clinical use since December 2008. DePuy Spine, Inc. will market the test for Axial and will feature SCOLISCORE at the Scoliosis Research Society (SRS) Annual Meeting taking place this week.